Literature DB >> 6208122

Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen.

B R Anger, K O Lloyd, H F Oettgen, L J Old.   

Abstract

Spleen cells from mice immunized with the human lung cancer line SK-LC-3 were fused with mouse NS-1 myeloma cells. One of the hybrid clones produced a monoclonal IgM antibody (designated F-3), detected with antimouse Ig-MHA and hemagglutination assays. This antibody was completely absorbed by O red cells and completely inhibited by low concentrations of H(O) glycoproteins and hog mucin (A + H). Bombay (Oh) red cells completely failed to absorb F-3 activity even after treatment with neuraminidase. A1, A2, A1B, A2B, and B red cells and A- and B-glycoproteins were less effective in absorbing or inhibiting F-3 activity. Other glycoproteins (including those having Lea or blood group precursor structures) showed little or no inhibitory activity. Serum from nude mice carrying F-3 hybridoma agglutinated O and A2 red cells at a titer of 1:40,000 and 1:640, respectively. A1, A1B, A2B, and B red cells were agglutinated with titers of 1:80 or less. Monoclonal antibody F-3 is, therefore, highly specific for H(O) blood group determinants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6208122     DOI: 10.1089/hyb.1.1982.1.139

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  4 in total

Review 1.  Peptide-displaying phage technology in glycobiology.

Authors:  Michiko N Fukuda
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

2.  Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure.

Authors:  K O Lloyd; G Larson; N Strömberg; J Thurin; K A Karlsson
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

Authors:  Y Fradet; C Cordon-Cardo; T Thomson; M E Daly; W F Whitmore; K O Lloyd; M R Melamed; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene.

Authors:  M J Telen; G S Eisenbarth; B F Haynes
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.